SOPHiA GENETICS (SOPH) Enterprise Value (2020 - 2025)

SOPHiA GENETICS's Enterprise Value history runs 6 years deep, the most recent figure standing at -$70.3 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 12.39% year-over-year to -$70.3 million; the TTM figure through Dec 2025 stood at -$70.3 million (up 12.39% YoY), while the FY2025 annual figure was -$70.3 million, up 12.39% from the prior year.
• Enterprise Value came in at -$70.3 million for Q4 2025 at SOPHiA GENETICS, up from -$81.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$42.5 million in Q2 2021 to a low of -$265.3 million in Q4 2021.
• A 5-year average of -$126.9 million and a median of -$114.3 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value jumped 45.17% in 2021 and sank 321.07% in 2022, its largest moves.
• SOPHiA GENETICS's Enterprise Value stood at -$265.3 million in 2021, then soared by 32.68% to -$178.6 million in 2022, then soared by 31.0% to -$123.3 million in 2023, then soared by 34.91% to -$80.2 million in 2024, then grew by 12.39% to -$70.3 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$70.3 million, -$81.6 million, and -$94.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison